745 related articles for article (PubMed ID: 20473303)
1. Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication.
Christ F; Voet A; Marchand A; Nicolet S; Desimmie BA; Marchand D; Bardiot D; Van der Veken NJ; Van Remoortel B; Strelkov SV; De Maeyer M; Chaltin P; Debyser Z
Nat Chem Biol; 2010 Jun; 6(6):442-8. PubMed ID: 20473303
[TBL] [Abstract][Full Text] [Related]
2. The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy.
Christ F; Debyser Z
Virology; 2013 Jan; 435(1):102-9. PubMed ID: 23217620
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule inhibitors of the LEDGF/p75 binding site of integrase block HIV replication and modulate integrase multimerization.
Christ F; Shaw S; Demeulemeester J; Desimmie BA; Marchand A; Butler S; Smets W; Chaltin P; Westby M; Debyser Z; Pickford C
Antimicrob Agents Chemother; 2012 Aug; 56(8):4365-74. PubMed ID: 22664975
[TBL] [Abstract][Full Text] [Related]
4. Structure-based virtual screening toward the discovery of novel inhibitors for impeding the protein-protein interaction between HIV-1 integrase and human lens epithelium-derived growth factor (LEDGF/p75).
Panwar U; Singh SK
J Biomol Struct Dyn; 2018 Sep; 36(12):3199-3217. PubMed ID: 28948865
[TBL] [Abstract][Full Text] [Related]
5. Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage.
Le Rouzic E; Bonnard D; Chasset S; Bruneau JM; Chevreuil F; Le Strat F; Nguyen J; Beauvoir R; Amadori C; Brias J; Vomscheid S; Eiler S; Lévy N; Delelis O; Deprez E; Saïb A; Zamborlini A; Emiliani S; Ruff M; Ledoussal B; Moreau F; Benarous R
Retrovirology; 2013 Nov; 10():144. PubMed ID: 24261564
[TBL] [Abstract][Full Text] [Related]
6. Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV.
Hombrouck A; De Rijck J; Hendrix J; Vandekerckhove L; Voet A; De Maeyer M; Witvrouw M; Engelborghs Y; Christ F; Gijsbers R; Debyser Z
PLoS Pathog; 2007 Mar; 3(3):e47. PubMed ID: 17397262
[TBL] [Abstract][Full Text] [Related]
7. 1,2,3,4-Tetrahydroisoquinolines as inhibitors of HIV-1 integrase and human LEDGF/p75 interaction.
George A; Gopi Krishna Reddy A; Satyanarayana G; Raghavendra NK
Chem Biol Drug Des; 2018 Jun; 91(6):1133-1140. PubMed ID: 29405651
[TBL] [Abstract][Full Text] [Related]
8. The Competitive Interplay between Allosteric HIV-1 Integrase Inhibitor BI/D and LEDGF/p75 during the Early Stage of HIV-1 Replication Adversely Affects Inhibitor Potency.
Feng L; Dharmarajan V; Serrao E; Hoyte A; Larue RC; Slaughter A; Sharma A; Plumb MR; Kessl JJ; Fuchs JR; Bushman FD; Engelman AN; Griffin PR; Kvaratskhelia M
ACS Chem Biol; 2016 May; 11(5):1313-21. PubMed ID: 26910179
[TBL] [Abstract][Full Text] [Related]
9. LEDGF/p75-independent HIV-1 replication demonstrates a role for HRP-2 and remains sensitive to inhibition by LEDGINs.
Schrijvers R; De Rijck J; Demeulemeester J; Adachi N; Vets S; Ronen K; Christ F; Bushman FD; Debyser Z; Gijsbers R
PLoS Pathog; 2012; 8(3):e1002558. PubMed ID: 22396646
[TBL] [Abstract][Full Text] [Related]
10. TALEN knockout of the PSIP1 gene in human cells: analyses of HIV-1 replication and allosteric integrase inhibitor mechanism.
Fadel HJ; Morrison JH; Saenz DT; Fuchs JR; Kvaratskhelia M; Ekker SC; Poeschla EM
J Virol; 2014 Sep; 88(17):9704-17. PubMed ID: 24942577
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the HIV-1 integrase chromatin- and LEDGF/p75-binding abilities by mutagenic analysis within the catalytic core domain of integrase.
Zheng Y; Ao Z; Jayappa KD; Yao X
Virol J; 2010 Mar; 7():68. PubMed ID: 20331877
[TBL] [Abstract][Full Text] [Related]
12. Identification of the LEDGF/p75 binding site in HIV-1 integrase.
Busschots K; Voet A; De Maeyer M; Rain JC; Emiliani S; Benarous R; Desender L; Debyser Z; Christ F
J Mol Biol; 2007 Feb; 365(5):1480-92. PubMed ID: 17137594
[TBL] [Abstract][Full Text] [Related]
13. New class of HIV-1 integrase (IN) inhibitors with a dual mode of action.
Tsiang M; Jones GS; Niedziela-Majka A; Kan E; Lansdon EB; Huang W; Hung M; Samuel D; Novikov N; Xu Y; Mitchell M; Guo H; Babaoglu K; Liu X; Geleziunas R; Sakowicz R
J Biol Chem; 2012 Jun; 287(25):21189-203. PubMed ID: 22535962
[TBL] [Abstract][Full Text] [Related]
14. The HIV-1 integrase-LEDGF allosteric inhibitor MUT-A: resistance profile, impairment of virus maturation and infectivity but without influence on RNA packaging or virus immunoreactivity.
Amadori C; van der Velden YU; Bonnard D; Orlov I; van Bel N; Le Rouzic E; Miralles L; Brias J; Chevreuil F; Spehner D; Chasset S; Ledoussal B; Mayr L; Moreau F; García F; Gatell J; Zamborlini A; Emiliani S; Ruff M; Klaholz BP; Moog C; Berkhout B; Plana M; Benarous R
Retrovirology; 2017 Nov; 14(1):50. PubMed ID: 29121950
[TBL] [Abstract][Full Text] [Related]
15. LEDGINs, Inhibitors of the Interaction Between HIV-1 Integrase and LEDGF/p75, Are Potent Antivirals with a Potential to Cure HIV Infection.
Debyser Z; Bruggemans A; Van Belle S; Janssens J; Christ F
Adv Exp Med Biol; 2021; 1322():97-114. PubMed ID: 34258738
[TBL] [Abstract][Full Text] [Related]
16. Phage display-directed discovery of LEDGF/p75 binding cyclic peptide inhibitors of HIV replication.
Desimmie BA; Humbert M; Lescrinier E; Hendrix J; Vets S; Gijsbers R; Ruprecht RM; Dietrich U; Debyser Z; Christ F
Mol Ther; 2012 Nov; 20(11):2064-75. PubMed ID: 22828501
[TBL] [Abstract][Full Text] [Related]
17. Quinoline-based Protein-protein Interaction Inhibitors of LEDGF/p75 and HIV Integrase: An In Silico Study.
Chhokar N; Kalra S; Chauhan M; Munshi A; Kumar R
Curr Top Med Chem; 2018; 18(32):2800-2815. PubMed ID: 30747071
[TBL] [Abstract][Full Text] [Related]
18. Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication.
Emiliani S; Mousnier A; Busschots K; Maroun M; Van Maele B; Tempé D; Vandekerckhove L; Moisant F; Ben-Slama L; Witvrouw M; Christ F; Rain JC; Dargemont C; Debyser Z; Benarous R
J Biol Chem; 2005 Jul; 280(27):25517-23. PubMed ID: 15855167
[TBL] [Abstract][Full Text] [Related]
19. Multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitors.
Kessl JJ; Jena N; Koh Y; Taskent-Sezgin H; Slaughter A; Feng L; de Silva S; Wu L; Le Grice SF; Engelman A; Fuchs JR; Kvaratskhelia M
J Biol Chem; 2012 May; 287(20):16801-11. PubMed ID: 22437836
[TBL] [Abstract][Full Text] [Related]
20. A new class of multimerization selective inhibitors of HIV-1 integrase.
Sharma A; Slaughter A; Jena N; Feng L; Kessl JJ; Fadel HJ; Malani N; Male F; Wu L; Poeschla E; Bushman FD; Fuchs JR; Kvaratskhelia M
PLoS Pathog; 2014 May; 10(5):e1004171. PubMed ID: 24874515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
